Simple Question:
If we show the same cognitive improvements ( or possibly better with different dosages in later trials) for the AD results, would there be the same negative reaction?? In my opinion: no.
AD was always the bigger market and the main focus.
I look forward to the AD results to hopefully put an end all of this conjecture.
Good luck to all holders
This is not financial advice.DYOR
congratulations prana, page-6
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.88M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $36.66K | 4.054M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 29377654 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 12877825 | 16 |
View Market Depth
| Last trade - 16.10pm 13/01/2025 (20 minute delay) ? |
| ATH (ASX) Chart |
